Novel Proteins, Peptides And Amino Acids With Health Benefits

PepsiCo is interested in proteins, peptides, amino acids that could be consumed for specific health needs across different human life stages.

Application Deadline
September 24th, 2025
Share this Challenge

Summary

Background

PepsiCo are a global leader in convenient foods and beverages. PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo's product portfolio includes a wide range of enjoyable foods and beverages, including many iconic brands that generate more than $1 billion each in estimated annual retail sales.

Challenge

PepsiCo is interested in proteins, peptides, amino acids that could be consumed for specific health needs across different human life stages. Proteins are typically consumed as a required macro nutrient for our diets. However, recent developments in the space show they could be more than a macro nutrient.

Must-Have requirements:

  •  Minimal / no impact on taste and texture of the powder and liquid beverage applications.
  •  Clinical evidence to show the unique value of the ingredient.
  •  GRAS or CFR compliance for food and beverage applications.
  •  Clear route to commercialization.

 Preferred requirements

  •  "Clean Label", i.e. easy to pronounce and common names (e.g. familiar, "kitchen" ingredients are highly desirable and avoid chemical-sounding ingredients).
  •  Clarity in solution in low and high-acid environments.
  •  Heat stable
  •  Non-GMO
  •  Commercially available

 Out of Scope:

  • Timing: This would be a H2/H3 initiative with 2-3 year timeline for potential product launches.
  • TRL- Level – 5-9 

What's in it for you?

Funding

Up to $60,000 funding for potential trials at pilot plants for production of consumer products.

Expertise

Collaboration with PepsiCo R&D technical teams to evaluate the ingredients in consumer facing products and provide insights for what is needed for successful commercialization of our products. Additionally, we can offer access to our internal experts on support on secondary clinical studies.

Technologies

We are open to receiving and testing samples, collaborating closely, and providing feedback to improve ingredients if needed. We can also arrange onsite meetings and tasting. Access to our labs or pilot plants will not be given.